Arthritis drug stops T-cells from going after joint tissue

The Bristol-Myers Squibb experimental medication works better to reduce joint pain in rheumatoid arthritis patients than conventional treatments, a study says. Researchers hope this drug, used in combination with other treatments, may achieve better results with fewer side effects.

View Full Article in:

Journal and Constitution (Atlanta) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC
Compliance Director
Abbott Laboratories
Santa Clara, CA